Forge Biologics to Present at 2021 Virtual Cell & Gene Meeting on the Mediterranean
News provided by
Share this article
Share this article
COLUMBUS, Ohio, April 6, 2021 /PRNewswire/ Forge Biologics, a cGMP manufacturing and development company, announced today that Timothy J. Miller, Ph.D., Chief Executive Officer, President, and Co-Founder will present at the annual Cell & Gene Meeting on the Mediterranean, which will be held virtually April 6-9, 2021.
Dr. Timothy J. Miller, Ph.D. will be presenting at Meeting on the Med on April 6-9th, 2021. View the full presentation at www.meetingonthemed.com.
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mediterranean is a four-day virtual conference featuring more than 80 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and br
Proactive news headlines: Oncimmune Holdings PLC, Alien Metals Ltd, Cornerstone FS PLC, Gore Street Energy Storage Fund PLC... proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
AGC Biologics to Present Their End-to-End Cell and Gene Therapy Offering at ARM s Meeting on the Mediterranean Conference
About AGC Biologics:
AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to deliver the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), viral vectors and genetically engineered cells. Our global network spans the U.S., Europe and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we currently employ more than 1,600 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients most complex challenges, including specialization in fast-track pr
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Celyad Oncology Announces April 2021 Conference Schedule
Celyad Oncology SAApril 1, 2021 GMT
MONT-SAINT-GUIBERT, Belgium, April 01, 2021 (GLOBE NEWSWIRE) Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in April 2021:
Cell & Gene Meeting on the Mediterranean Dates: April 6-9, 2021 Panel Participant: Filippo Petti, CEO Panel Webcast: Available on-demand through the conference website starting Thursday, April 8 Company Presentation: Available on-demand through the conference website starting Tuesday, April 6
Celyad Oncology SA: Celyad Oncology Announces April 2021 Conference Schedule finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.